CD274 and esophageal squamous cell carcinoma: Endoscopic or surgical treatment is practiced in patients at early-stage, while radiotherapy or chemotherapy is predominant for advanced or metastatic ESCC.5 Immunotherapy with pembrolizumab, the antibody against PD-1, was recently approved for therapy of ESCC with high expression of PD-L1.